Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: A report from the Children's Cancer Group. - Sievers,E.L.; Lange,B.J.; Sondel,P.M.; Krailo,M.D.; Gan,J.; Liu-Mares,W.; Feig,S.A. (J Clin Oncol, 1998)